Last Week’s Top Ten: Kindler Talks Wyeth, ARCA Makes News and Lots of Interest in Vatalanib
May 24, 2009 at 2:00 pm EST | Tags: The Top Ten
It’s time for last week’s Top Ten!! This week was saturated with CTIC posts and of course, that guy who doesn’t put Baby in a corner. OK, let’s get to it – the most read posts of the week — the posts that made us all laugh, cry, gasp and say OMG!!! — The Top Ten!
10 – Pfizer’s Jeff Kindler Speaks with CNBC, Talks Wyeth and Free Drugs
9 – Why is ARCA Biopharma Down Today?
8 – More Cell Therapeutics: OPAXIO vs. Pixantrone, The Race is On
7 – ASCO Watch 09: Genta, Exelixis, Roche/Genentech, Cell Therapeutics
6 – An Exhausted Genasense Nears Its End…
5 – The Pixantrone “Ghost Post”…Plus Today’s Safety Data (Our Take)
4 – Cell Therapeutics Responds…
3 – Did Vatalanib Work for Patrick Swayze?
2 – Cell Therapeutics’ Pixantrone: Hype or Truth?
And the #1 post of last week is….
1 – Pixantrone Data…by Popular Demand
Have a good Sunday everyone!!!
Anonymous Tip? Comments? Contact us at: hr@iguanabio.com
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
